NDC 73190-004 – Memantine and Donepezil Hydrochlorides Extended-release
Memantine Hydrochloride 28 mg/1; Donepezil Hydrochloride 10 mg/1 · Capsule, Extended Release · Oral
Product NDC73190-004
Product details
- Brand name
- Memantine and Donepezil Hydrochlorides Extended-release
- Generic name
- Memantine and Donepezil
- Labeler
- AvKARE
- Dosage form
- Capsule, Extended Release
- Route
- Oral
- Marketing category
- ANDA · ANDA208328
- Marketed since
- February 6, 2025
- Listing expires
- December 31, 2026
- Pharmacologic class
- Cholinesterase Inhibitor; N-methyl-D-aspartate Receptor Antagonist
Active ingredients
- Memantine Hydrochloride 28 mg/1
- Donepezil Hydrochloride 10 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 73190-004-30 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (73190-004-30) | Feb 6, 2025 |
Other Memantine and Donepezil Hydrochlorides Extended-release products
- 69238-1247 Memantine Hydrochloride 28 mg/1; Donepezil Hydrochloride 10 mg/1 · Capsule, Extended Release · Amneal Pharmaceuticals NY LLC
- 69238-1248 Memantine Hydrochloride 14 mg/1; Donepezil Hydrochloride 10 mg/1 · Capsule, Extended Release · Amneal Pharmaceuticals NY LLC
- 69238-1552 Memantine Hydrochloride 7 mg/1; Donepezil Hydrochloride 10 mg/1 · Capsule, Extended Release · Amneal Pharmaceuticals NY LLC
- 69238-1553 Memantine Hydrochloride 21 mg/1; Donepezil Hydrochloride 10 mg/1 · Capsule, Extended Release · Amneal Pharmaceuticals NY LLC